Heart Failure Treatment Guidelines

First-Line Pharmacological Therapy

The European Society of Cardiology recommends ACE inhibitors as first-line therapy in patients with reduced left ventricular systolic function 3
Diuretics are essential for symptomatic treatment when fluid overload is present, such as pulmonary congestion or peripheral edema, as recommended by the European Society of Cardiology 2, 3
The European Society of Cardiology recommends beta-blocking agents for all patients with stable mild, moderate, and severe heart failure with reduced LV ejection fraction in NYHA class II-IV on standard treatment 1

The European Society of Cardiology recommends starting with a low dose and building up to recommended maintenance dosages of ACE inhibitors 1
The European Society of Cardiology recommends monitoring blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment, at 3 months, and subsequently at 6-month intervals for patients on ACE inhibitors 1
The European Society of Cardiology recommends avoiding excessive diuresis before starting ACE inhibitor treatment and reducing or withholding diuretics for 24 hours if possible 2
The European Society of Cardiology recommends avoiding NSAIDs during ACE inhibitor therapy 1

The European Society of Cardiology recommends explaining heart failure pathophysiology, symptoms recognition, and self-management to patients 2
The European Society of Cardiology encourages daily physical and leisure activities in stable patients to prevent muscle deconditioning 2
The European Society of Cardiology recommends controlling sodium intake when necessary, especially in severe heart failure 1
The European Society of Cardiology recommends avoiding excessive fluids in severe heart failure 1
The European Society of Cardiology recommends avoiding excessive alcohol intake 1
The European Society of Cardiology considers exercise training programs in stable NYHA II-III patients 2

For NYHA Class II (Mild Heart Failure), the European Society of Cardiology recommends ACE inhibitor titrated to recommended target doses, adding beta-blocker and titrating to target dosages, and using diuretics as needed during episodes of fluid overload 6
For NYHA Class III-IV (Moderate to Severe Heart Failure), the European Society of Cardiology recommends diuretics plus ACE inhibitors, adding beta-blockers, and considering spironolactone for advanced heart failure 6

The European Society of Cardiology recommends avoiding potassium-sparing diuretics during initiation of ACE inhibitor therapy 1
The European Society of Cardiology recommends monitoring for hypotension when starting ACE inhibitors or beta-blockers 4
The European Society of Cardiology advises against using beta-blockers in patients with asthma, severe bronchial disease, or symptomatic bradycardia/hypotension 4
The European Society of Cardiology recommends reserving routine inotropic therapy for severe episodes of heart failure, as it increases mortality 4